Developing an HbA1c-Based Equation to Estimate Blood Glucose in Maintenance Hemodialysis Patients
暂无分享,去创建一个
Junichi Hoshino | Kamyar Kalantar-Zadeh | K. Kalantar-Zadeh | C. Kovesdy | Y. Ubara | M. Molnar | K. Yamagata | J. Hoshino | Csaba P. Kovesdy | Kunihiro Yamagata | Miklos Z. Molnar | Yoshifumi Ubara | Kenmei Takaichi | K. Takaichi
[1] M. Emoto,et al. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] Kazuhiko Kawahara,et al. Stringent glycaemic control prolongs survival in diabetic patients with end‐stage renal disease on haemodialysis , 2010, Nephrology.
[3] B. Freedman,et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.
[4] K. Kalantar-Zadeh,et al. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. , 2010, Kidney international. Supplement.
[5] K. Park,et al. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system. , 2010, Diabetes technology & therapeutics.
[6] D. Raj,et al. Hypercatabolism in dialysis patients , 2008, Current opinion in nephrology and hypertension.
[7] M. Rocco,et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[8] D. Goldstein,et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.
[9] T. Uzu,et al. Target for Glycemic Control in Type 2 Diabetic Patients on Hemodialysis: Effects of Anemia and Erythropoietin Injection on Hemoglobin A1c , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[10] K. Kalantar-Zadeh,et al. Association of Pretransplant Glycemic Control With Posttransplant Outcomes in Diabetic Kidney Transplant Recipients , 2011, Diabetes Care.
[11] S. Greenland,et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] K. Kalantar-Zadeh,et al. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] K. Kalantar-Zadeh,et al. Glycemic Control and Burnt‐Out Diabetes in ESRD , 2010, Seminars in dialysis.
[14] S. Anker,et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. , 2010, Mayo Clinic proceedings.
[15] D. Schoenfeld,et al. Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.
[16] J. Bargman,et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus , 2012, International Urology and Nephrology.
[17] Keith C. Norris,et al. Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients , 2010, American Journal of Nephrology.
[18] S. E. Park,et al. Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction , 2012, Diabetes Care.